FREE SHIPPING with every SuperJeweler.com order! Shop Now
Published On: Fri, Aug 23rd, 2019

GSK drug boosts response rates in blood cancer patients: study

British Drugmaker GlaxoSmithKline on Friday said its experimental cancer treatment belantamab mafodotin met the primary goal of a study for the treatment of patients with a type of blood cancer.


Reuters: Health News

FREE SHIPPING with every SuperJeweler.com order! Shop Now

About the Author

-

Leave a comment

XHTML: You can use these html tags: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>

Advertisements

Powered by WP Robot

GSK drug boosts response rates in blood cancer patients: study